Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RVRCRevium Rx.

OTC · CIK 0001839140
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts97

Identity from submissions API

NameRevium Rx.
CIK0001839140
TickersRVRC
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN844516676
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone6467684285
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
SUITE 500
NEW YORK
NY
10151
NY
Mailing address
C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
SUITE 500
NEW YORK
NY
10151
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

14 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-120597 333-284934 261560329 34 17915
2026-08-13 10-Q QUARTERLY REPORT 0001213900-26-089070 333-284934 261273076 34 2297429 1 1
2026-06-22 8-K CURRENT REPORT 5.02 0001213900-26-070415 333-284934 261105253 34 182451 1 1
2026-06-01 8-K CURRENT REPORT 5.02 0001213900-26-063235 333-284934 261047788 34 183779 1 1
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056600 333-284934 26978775 34 2295254 1 1
2026-04-20 8-K CURRENT REPORT 5.02,9.01 0001213900-26-045633 333-284934 26875473 34 374815 1 1
2026-03-31 10-K ANNUAL REPORT 0001213900-26-037573 333-284934 26823068 34 7036194 1 1
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000363 333-284934 26585484 33 1865
2026-01-28 S-1/A AMENDMENT NO. 5 TO FORM S-1 0001213900-26-008804 333-284934 26572404 33 11407298
2026-01-16 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-26-005242 333-284934 26540368 33 2597252
2025-12-12 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-25-121070 333-284934 251567371 33 2635889
2025-10-03 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-096094 333-284934 251374054 33 2657628
2025-08-13 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-075747 333-284934 251212408 33 2407215
2025-02-14 S-1 REGISTRATION STATEMENT 0001213900-25-013823 333-284934 25623584 33 23178842 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (97 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 60.73M 2026-08-13 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
dei EntityPublicFloat Entity Public Float USD 14.30M 2025-06-30 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 620,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 575,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 461,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 31.89M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 111,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 111,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 14.49M 2024-07-24 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 14.49M 2024-07-24 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap Assets Assets USD 7.11M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AssetsCurrent Assets, Current USD 1.86M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap AssetsNoncurrent Assets, Noncurrent USD 5.25M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 842,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 842,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -836,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 60.73M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 60.73M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap CommonStockValue Common Stock, Value, Issued USD 61,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 9.22M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 664,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap Depreciation Depreciation USD 2,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 575,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056600
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 575,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.02 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.02 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -131,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 96,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 555,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap Goodwill Goodwill USD 2.58M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 11.41M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 8.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD -845,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 358,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -226,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 2.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 457,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD -309,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -34,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap IndefinitelivedIntangibleAssetsAcquired Indefinite-lived Intangible Assets Acquired USD 3.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 2.50M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 2.50M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap Liabilities Liabilities USD 1.59M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 7.11M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap LiabilitiesCurrent Liabilities, Current USD 971,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 619,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 770,000 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 331,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.17M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.47M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.47M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 84,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 44,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 172,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 18,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap OtherAssetsCurrent Other Assets, Current USD 341,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OtherCommitment Other Commitment USD 1.33M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 284,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap PaymentsForFees Payments for Other Fees USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -350,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 19,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 916,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 9,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -26.43M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap SeveranceCosts1 Severance Costs USD 45,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 111,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 0.3 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-07-24 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.85 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.045 2024-07-24 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.53M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.29 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.53M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0.29 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056600
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 111,000 2026-06-10 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap SharePrice Share Price USD/shares 1.67 2026-06-10 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 5.52M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 5.52M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 437,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037573
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 60.73M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 60.73M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089070

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →